Potential Role of Somatostatin Receptor Scintigraphy for In Vivo Imaging of Vulnerable Atherosclerotic Plaques and Its Association with Myocardial Perfusion Imaging Finding: A Preliminary Study

• Published in: Molecular imaging and radionuclide therapy Vol. 32; no. 2; pp. 123 - 130
• Main Authors: Amini, Abdullatif, Jafari, Esmail, Pourbehi, Mohammad Reza, Iranpour, Dariush, Nemati, Reza, Ahmadzadehfar, Hojjat, Assadi, Majid
• Format: Journal Article
• Language: English
• Published: Turkey Galenos Publishing House 01.06.2023; Galenos Publishing
• Subjects: Angiography; Arteriosclerosis; Atherosclerosis; Cardiovascular disease; Computed tomography; Coronary artery; Coronary vessels; Emission analysis; Heart; Medical imaging; Neuroendocrine tumors; Nuclear medicine; Octreotide; Original; Perfusion; Photon emission; Plaques; Receptors; Risk factors; Scintigraphy; Single photon emission computed tomography; Somatostatin; Statistical analysis; Tomography; Ultrasonic imaging; myocardial perfusion scintigraphy; Tc-99m-octreotide; coronary angiography; somatostatin receptor-2 (SSTR-2)
• ISSN: 2146-1414; 2147-1959
• DOI: 10.4274/mirt.galenos.2022.08860

This study was conducted to detect atherosclerotic plaques with somatostatin receptor scintigraphy (SRS) using Tc-99m-octreotide that binds to somatostatin receptor-2. Of the 783 patients referred for myocardial perfusion imaging (MPI), 52 underwent additional chest single-photon emission computed tomography (SPECT) with Tc-99m-octreotide and participated in this study. In addition, 43 patients who underwent Tc-99m-octreotide scan for neuroendocrine tumor (NET) also received cardiac SPECT. Angiography was performed within 1 month after SRS for 19 patients who showed intensive uptake in SRS and had cardiac risk factors. Of 52 patients who underwent MPI and SRS, 15 showed intensive cardiac uptake in SRS. Moreover, of 43 patients who were referred for NET, 4 patients had marked cardiac uptake in SRS in the heart. Nineteen patients including 12 women and 7 men aged 28 to 84 (58±8.04) years underwent coronary angiography. SRS and angiography in the left anterior descending territory were concordant in 15/19 (79%) patients, whereas only 7/15 (46%) cases had concordant MPI and angiography results. In the right coronary artery territory, SRS and angiography were concordant in 16/19 (84%) cases, while MPI and angiography were concordant in 11/15 (73%) cases. In the left circumflex artery territory, SRS and angiography were concordant in 15/19 (79%) cases, whereas MPI and angiography were concordant in 6/15 (40%) cases. In the remaining 76 patients who did not undergo coronary angiography based on cardiovascular profile and SRS, no cardiac events occurred in a follow-up of 2-11 months (7.52±2.71). Tc-99m-octreotide uptake was more concordant with coronary plaques relative to MPI findings, suggesting a potential role for Tc-99m-octreotide in the evaluation of atherosclerosis.